(Q83054767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Association between IFN-alpha and primary Sjogren's syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Lingyan Zheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zhiyuan Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chuangqi Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Liwei Tu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Laiping Zhong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chi Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

e12-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

Sjögren's syndrome criteria

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Genetic aspects of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Update in Sjögren syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

The possible etiopathogenic genes of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Hepatitis C virus and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Viruses contribute to the development of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Evidence for coxsackievirus infection in primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Dendritic cells, chemokine receptors and autoimmune inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Interferon alfa treatment for Sjogren's syndrome associated neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

Expression of aquaporin-5 in and fluid secretion from immortalized human salivary gland ductal cells by treatment with 5-aza-2'-deoxycytidine: a possibility for improvement of xerostomia in patients with Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

The future of biologic agents in the treatment of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.09.015

10.1016/J.TRIPLEO.2008.09.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19101478%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference